Nieuws - hollandbio

CEPI launches COVAX Marketplace to match buyers and sellers of critical manufacturing supplies and speed up global access to COVID-19 vaccines through COVAX

16 juli 2021

ISA announces successful closing of EUR 26 million funding round

16 juli 2021

Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol’s active metabolite

12 juli 2021

Kamer wil stille pandemie van antibioticaresistentie bestrijden

9 juli 2021

Qorium raises € 2.6 mln to further develop its truly sustainable cultivated leather technology

9 juli 2021

Viewpoint Molecular Targeting® Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program

9 juli 2021

Leestip: Universiteit, faciliteer een ondernemend ecosysteem

6 juli 2021

Het effect van “Verder met Vaccineren”

6 juli 2021

HollandBIO welcomes InnoSer and C-Path as new members

6 juli 2021

MIMETAS and Roche enter into a collaboration to develop human disease models for drug development

6 juli 2021

Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema

5 juli 2021

Drie wisselingen in het bestuur van HollandBIO

29 juni 2021

HollandBIO welcomes EV Biotech as a new member

29 juni 2021

Zorginstituut: Nederlands vaccinatiebeleid moet beter, meer regie nodig

29 juni 2021

BioConnection ontvangt GMP-certificaat en productielicentie van Inspectie Gezondheidszorg en Jeugd (IGJ) voor nieuwe productielijn steriele geneesmiddelen

29 juni 2021

Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer

29 juni 2021

European Innovation Scoreboard: Nederland geen innovatieleider meer

29 juni 2021

ProBioGen and LAVA Therapeutics N.V. Sign Agreement for Cell Line Development for Manufacturing of a Novel Bispecific

29 juni 2021

Breakingbiotechnews!

CEPI launches COVAX Marketplace to match buyers and sellers of critical manufacturing supplies and speed up global access to COVID-19 vaccines through COVAX

ISA announces successful closing of EUR 26 million funding round

Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol’s active metabolite

Kamer wil stille pandemie van antibioticaresistentie bestrijden

Qorium raises € 2.6 mln to further develop its truly sustainable cultivated leather technology

Viewpoint Molecular Targeting® Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program

Leestip: Universiteit, faciliteer een ondernemend ecosysteem

Het effect van “Verder met Vaccineren”

HollandBIO welcomes InnoSer and C-Path as new members

MIMETAS and Roche enter into a collaboration to develop human disease models for drug development

Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema

Drie wisselingen in het bestuur van HollandBIO

HollandBIO welcomes EV Biotech as a new member

Zorginstituut: Nederlands vaccinatiebeleid moet beter, meer regie nodig

BioConnection ontvangt GMP-certificaat en productielicentie van Inspectie Gezondheidszorg en Jeugd (IGJ) voor nieuwe productielijn steriele geneesmiddelen

Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer

European Innovation Scoreboard: Nederland geen innovatieleider meer

ProBioGen and LAVA Therapeutics N.V. Sign Agreement for Cell Line Development for Manufacturing of a Novel Bispecific

Breaking
biotech
news!